Israel Pharmaceuticals & Healthcare Report Q4 2013: New Research Report Available at Fast Market Research
Israel's pharmaceutical market is a very attractive prospect for multinationals looking to launch innovative medicines. Favourable factors include high per capita spending on medicines, a market size approaching US$2bn, a high proportion of pensioners and a largely urbanised population. However, we caution that poor patent respect and a lack of business transparency remain key threats to company revenues. Additionally, we hold a relatively less optimistic outlook for growth in the market, based on weaker private consumption over the medium term.
View full press release